Tekla Capital Management LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2020$1,220,000
-86.4%
32,400
-85.3%
0.05%
-86.5%
Q2 2020$8,985,000
+14.6%
220,263
+6.5%
0.34%
-3.4%
Q1 2020$7,838,000
-35.1%
206,868
-19.5%
0.35%
-22.5%
Q4 2019$12,079,000
+22.1%
257,048
+10.9%
0.46%
+5.8%
Q3 2019$9,891,000
+13.0%
231,758
+6.0%
0.43%
+21.0%
Q2 2019$8,752,000
-4.2%
218,7000.0%0.36%
-3.8%
Q1 2019$9,139,000
+9.4%
218,7000.0%0.37%
+3.6%
Q4 2018$8,357,000
-4.9%
218,7000.0%0.36%
+12.2%
Q3 2018$8,785,000
-39.3%
218,700
-39.1%
0.32%
-41.9%
Q2 2018$14,471,000
-6.2%
359,000
-9.1%
0.55%
-8.5%
Q1 2018$15,423,000
+21.1%
394,749
+10.0%
0.60%
+22.2%
Q4 2017$12,734,000
-12.6%
359,0000.0%0.49%
-5.8%
Q3 2017$14,575,000
-5.8%
359,0000.0%0.52%
-9.1%
Q2 2017$15,480,000
+2.3%
359,0000.0%0.57%
-2.4%
Q1 2017$15,135,000
+9.5%
359,0000.0%0.59%
-0.3%
Q4 2016$13,825,000
-10.7%
359,0000.0%0.59%
-1.0%
Q3 2016$15,484,000
-29.9%
359,000
-29.5%
0.60%
-34.0%
Q2 2016$22,077,000
+91.0%
509,400
+78.7%
0.90%
+83.1%
Q1 2016$11,557,000
+0.5%
285,0000.0%0.49%
+18.0%
Q4 2015$11,500,000
+4.9%
285,0000.0%0.42%
+5.8%
Q3 2015$10,958,000285,0000.39%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders